Physician profile
Eric Yuen
NPI 1598765968
$1,904.03
in general payments reported to CMS, 2019-2025
8 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $59.24 · 2021: $384 · 2022: $844 · 2023: $145 · 2024: $120 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $390.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $934.43 | 2019-2022 | |
| Abbott Laboratories | $424.52 | 2022 | |
| Kestra Medical Technology Services, INC. | $144.50 | 2023 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $126.10 | 2025 | Amvuttra |
| Merck Sharp & Dohme LLC | $121.26 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $120.25 | 2024 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $20.48 | 2019 | |
| Mylan Specialty L.P. | $12.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Yuen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.